Materialise NV reports developments in additive manufacturing software, 3D printing services, and 3D-printed medical devices. The Belgium-based foreign issuer trades on Nasdaq through ADSs and has ordinary shares listed on Euronext Brussels. Company updates commonly cover operating and financial results, segment trends in Materialise Medical, Materialise Software, and Materialise Manufacturing, and the role of 3D printing solutions across healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods.
Recurring announcements also include earnings-call schedules, annual and extraordinary shareholder meeting actions, regulated information under Belgian market rules, voting-rights and share-count notices, and changes affecting specific activities within the company’s 3D printing portfolio.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.